CUSIP: 92852W303
Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
719,362
-
Share change
-
+227,753
-
Total reported value
-
$905,000
-
Price per share
-
$1.26
-
Number of holders
-
9
-
Value change
-
+$160,576
-
Number of buys
-
6
-
Number of sells
-
4
Quarterly Holders Quick Answers
What is CUSIP 92852W303?
CUSIP 92852W303 identifies 92852W303 - VIVEVE MED INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2020
-
Previous quarter:
Q3 2019
Recent filing periods for CUSIP 92852W303:
Institutional Holders of VIVEVE MED INC - COM as of Q4 2019
As of 31 Dec 2019,
VIVEVE MED INC - COM was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
719,362 shares.
The largest 9 holders included
HighTower Advisors, LLC, A.R.T. Advisors, LLC, Alyeska Investment Group, L.P., BOOTHBAY FUND MANAGEMENT, LLC, Virtu Financial LLC, BANK OF MONTREAL /CAN/, 5AM Venture Management, LLC, BlackRock Inc., and UBS Group AG.
This page lists
9
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.